Telomir Pharmaceuticals Statistics
NASDAQ: TELOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.364-0.0758 (-17.24%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Telomir Pharmaceuticals by the numbers
Telomir Pharmaceuticals has a market capitalization of $26.8 million based on 73.68M shares outstanding. With trailing EPS of $-0.96, Telomir Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 62.2% below its 50-day average and 69.0% below its 200-day average.
Average daily trading volume is 126.14K shares, or about $45,916 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TELO valuation vs. peer median
| Metric | TELO | Peer median | Difference |
|---|---|---|---|
| Market cap | $26.82M | $28.67M | -6% |
| Avg. volume | 126.14K | 207.85K | -39% |
Peer median across 8 companies: NSRX, BCTX, EDSA, PMN, AYTU, ATHE, RNTX, NNVC.
Valuation
- Market cap
- $26.82M
- EPS (TTM)
- $-0.96
- Shares outstanding
- 73.68M
Price and trading
- Previous close
- 0.4398
- Open
- 0.43
- Day range
- 0.3578 – 0.4371
- 52-week range
- 0.353 – 1.58
- 52-week change
- -71.56%
- 50-day moving average
- 0.9636
- Beta
- —
- Volume
- 255.91K
- Average volume
- 126.14K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2025
Additional statistics
- Market Cap
- 26.82M
- Forward Pe
- -1.30
- Eps
- -0.96
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 1.58
- Week52 Low
- 0.35
- Avg Volume
- 126.14K
- Shares Outstanding
- 73.68M
- Ma50
- 0.96
- Ma200
- 1.17
- Earnings Date
- Aug 11, 2025
- Pct From52w High
- -76.96%
- Pct From52w Low
- 3.12%